BWXT ITG
GenericsBWXT ITG is a generic drug manufacturer focused on Infectious Disease.
BWXT ITG's Key Drugs
BWXT ITG's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
BWXT ITG's Recent FDA Approvals
New NDA/BLA approvals for BWXT ITG over the last two years — novel drugs only, excluding generics and label supplements.
BWXT ITG's Therapeutic Areas
BWXT ITG's approved drugs and pipeline span 1 therapeutic area, led by Infectious Disease, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
BWXT ITG's Top Competitors
BWXT ITG's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
BWXT ITG Pipeline Snapshot
Active clinical trials for BWXT ITG across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2018-07-25
- Latest
- 2018-07-25
- Applications
- 1